Bruker Corp (BKD.BE)
| Previous close | 75.34 |
| Open | 73.14 |
| Bid | 73.00 x 0 |
| Ask | 73.50 x 0 |
| Day's range | 73.14 - 73.14 |
| 52-week range | 52.00 - 86.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireBruker Reports First Quarter 2024 Financial Results
BILLERICA, Mass., May 02, 2024--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2024.
Business WireBruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
TORINO, Italy, May 02, 2024--Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup ("ELITech") for €870 million in cash, excluding the carved out ELITech clinical chemistry business. ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology, with FY 2023 revenue of approximately EUR 150 million, and more than 80% consumables revenue.
Simply Wall St.Bruker Corporation's (NASDAQ:BRKR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
With its stock down 17% over the past month, it is easy to disregard Bruker (NASDAQ:BRKR). However, stock prices are...
